CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: ergoline alkaloid
Accession: CHEBI:60529
browse the term
Definition: One of a class of naturally occurring alkaloids with a structure based on that of ergoline.
Synonyms: related_synonym: ergoline alkaloids
G
Abcb4
ATP binding cassette subfamily B member 4
decreases activity
ISO
Methysergide results in decreased activity of ABCB4 protein
CTD
PMID:28437613
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Adra1a
adrenoceptor alpha 1A
multiple interactions
EXP
Methysergide promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA1A protein]
CTD
PMID:16545797
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
G
Calca
calcitonin-related polypeptide alpha
affects activity
EXP
Methysergide affects the activity of CALCA protein
CTD
PMID:10075105
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Htr1b
5-hydroxytryptamine receptor 1B
affects binding
EXP
Methysergide binds to HTR1B protein
CTD
PMID:11888550
NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:82,517,360...82,534,549
G
Htr2b
5-hydroxytryptamine receptor 2B
multiple interactions
ISO
Methylergonovine binds to and results in increased activity of HTR2B protein
CTD
PMID:11104741
NCBI chr 9:86,735,793...86,756,638
Ensembl chr 9:86,742,102...86,755,108
G
Ifng
interferon gamma
decreases expression
ISO
fumigaclavine C results in decreased expression of IFNG mRNA; fumigaclavine C results in decreased expression of IFNG protein
CTD
PMID:16023606
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il12a
interleukin 12A
decreases expression
ISO
fumigaclavine C results in decreased expression of IL12A mRNA
CTD
PMID:16023606
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
G
Il1b
interleukin 1 beta
decreases expression
ISO
fumigaclavine C results in decreased expression of IL1B mRNA
CTD
PMID:16023606
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
decreases expression
ISO
fumigaclavine C results in decreased expression of IL2 mRNA; fumigaclavine C results in decreased expression of IL2 protein
CTD
PMID:16023606
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Mmp9
matrix metallopeptidase 9
decreases activity decreases expression
ISO
fumigaclavine C results in decreased activity of MMP9 protein fumigaclavine C results in decreased expression of MMP9 mRNA
CTD
PMID:16023606
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Tnf
tumor necrosis factor
decreases expression
ISO
fumigaclavine C results in decreased expression of TNF mRNA
CTD
PMID:16023606
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Adra1a
adrenoceptor alpha 1A
multiple interactions
EXP
Lisuride binds to and results in decreased activity of ADRA1A protein; Lisuride promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA1A protein]
CTD
PMID:16545797
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
G
Htr7
5-hydroxytryptamine receptor 7
multiple interactions
ISO
[Lisuride binds to and results in decreased activity of HTR7 protein] inhibits the reaction [Colforsin results in increased abundance of Cyclic AMP]; Lisuride binds to and results in decreased activity of HTR7 protein
CTD
PMID:18996971 PMID:19509219
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
G
Ifng
interferon gamma
increases expression
ISO
Lisuride results in increased expression of IFNG
CTD
PMID:7948314
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Prl
prolactin
multiple interactions decreases secretion
ISO EXP
Lisuride inhibits the reaction [Metoclopramide results in increased secretion of PRL protein]; Lisuride results in decreased expression of and results in decreased secretion of PRL protein Lisuride analog results in decreased secretion of PRL protein; Lisuride results in decreased secretion of PRL protein
CTD
PMID:386688 PMID:6492995
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Lisuride inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Drd2
dopamine receptor D2
affects binding
EXP
LSD binds to Drd2 protein
RGD
PMID:15852061
RGD:1581406
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Lysergic Acid Diethylamide results in increased expression of FOS mRNA
CTD
PMID:10521585
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Htr2b
5-hydroxytryptamine receptor 2B
multiple interactions affects binding
ISO
2-aminoindan analog inhibits the reaction [Lysergic Acid Diethylamide binds to HTR2B protein]; Lysergic Acid Diethylamide analog binds to and results in increased activity of HTR2B protein; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Lysergic Acid Diethylamide binds to HTR2B protein]
CTD
PMID:14659797 PMID:29458138
NCBI chr 9:86,735,793...86,756,638
Ensembl chr 9:86,742,102...86,755,108
G
Htr5b
5-hydroxytryptamine (serotonin) receptor 5B
multiple interactions
EXP
lysergic acid diethylamide binds to protein 5-Htr5b; inhibits the reaction[5-carboxamidotryptamine binds to 5-Htr5b]
RGD
PMID:8224165
RGD:2303647
NCBI chr13:32,686,911...32,699,835
Ensembl chr13:32,687,042...32,699,835
G
Htr6
5-hydroxytryptamine receptor 6
affects binding
ISO
Lysergic Acid Diethylamide binds to HTR6 protein
CTD
PMID:21866910
NCBI chr 5:151,295,269...151,312,853
Ensembl chr 5:151,296,662...151,311,912
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
lysergol inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Htr2b
5-hydroxytryptamine receptor 2B
affects binding multiple interactions
ISO
mesulergine binds to HTR2B protein Fluoxetine promotes the reaction [mesulergine binds to HTR2B protein]
CTD
PMID:11930908
NCBI chr 9:86,735,793...86,756,638
Ensembl chr 9:86,742,102...86,755,108
G
Htr2c
5-hydroxytryptamine receptor 2C
affects binding multiple interactions
ISO EXP
mesulergine binds to HTR2C protein N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [mesulergine binds to HTR2C protein] Carbamazepine inhibits the reaction [Pilocarpine affects the reaction [mesulergine binds to HTR2C protein]]; Carbamazepine inhibits the reaction [Pilocarpine inhibits the reaction [mesulergine binds to HTR2C protein]]; Pilocarpine affects the reaction [mesulergine binds to HTR2C protein]; Pilocarpine inhibits the reaction [mesulergine binds to HTR2C protein]; Plant Extracts inhibits the reaction [Pilocarpine affects the reaction [mesulergine binds to HTR2C protein]]; Plant Extracts inhibits the reaction [Pilocarpine inhibits the reaction [mesulergine binds to HTR2C protein]]
CTD
PMID:18083778 PMID:19439326 PMID:19700373 PMID:29458138
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Htr7
5-hydroxytryptamine receptor 7
affects binding multiple interactions
ISO
mesulergine binds to HTR7 protein [mesulergine binds to and results in decreased activity of HTR7 protein] inhibits the reaction [5-carboxamidotryptamine results in increased abundance of Cyclic AMP]; mesulergine inhibits the reaction [Risperidone binds to and results in decreased activity of HTR7 protein]
CTD
PMID:14578406 PMID:20827463
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
G
Prl
prolactin
multiple interactions
EXP
mesulergine inhibits the reaction [Diethylstilbestrol results in increased secretion of PRL protein]
CTD
PMID:1421203
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Ddc
dopa decarboxylase
increases activity
ISO
Metergoline results in increased activity of DDC protein
CTD
PMID:16415089
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Htr1b
5-hydroxytryptamine receptor 1B
affects binding
EXP
Metergoline binds to HTR1B protein
CTD
PMID:11888550
NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:82,517,360...82,534,549
G
Htr2a
5-hydroxytryptamine receptor 2A
multiple interactions
ISO
[Metergoline binds to and results in decreased activity of HTR2A protein] which results in decreased susceptibility to Cocaine
CTD
PMID:10764922
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Htr7
5-hydroxytryptamine receptor 7
multiple interactions
ISO
[Metergoline binds to and results in decreased activity of HTR7 protein] inhibits the reaction [5-carboxamidotryptamine results in increased abundance of Cyclic AMP]; [Metergoline binds to and results in decreased activity of HTR7 protein] inhibits the reaction [Colforsin results in increased abundance of Cyclic AMP]; Metergoline binds to and results in decreased activity of HTR7 protein
CTD
PMID:14578406 PMID:18996971 PMID:19509219
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
G
Htr2b
5-hydroxytryptamine receptor 2B
multiple interactions
ISO
Methylergonovine binds to and results in increased activity of HTR2B protein
CTD
PMID:11104741
NCBI chr 9:86,735,793...86,756,638
Ensembl chr 9:86,742,102...86,755,108
G
Abcb4
ATP binding cassette subfamily B member 4
decreases activity
ISO
Methysergide results in decreased activity of ABCB4 protein
CTD
PMID:28437613
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Adra1a
adrenoceptor alpha 1A
multiple interactions
EXP
Methysergide promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA1A protein]
CTD
PMID:16545797
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
G
Calca
calcitonin-related polypeptide alpha
affects activity
EXP
Methysergide affects the activity of CALCA protein
CTD
PMID:10075105
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Htr1b
5-hydroxytryptamine receptor 1B
affects binding
EXP
Methysergide binds to HTR1B protein
CTD
PMID:11888550
NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:82,517,360...82,534,549
G
Htr5b
5-hydroxytryptamine (serotonin) receptor 5B
multiple interactions
EXP
methysergide binds to protein 5-Htr5b; inhibits the reaction[5-carboxamidotryptamine binds to 5-Htr5b]
RGD
PMID:8224165
RGD:2303647
NCBI chr13:32,686,911...32,699,835
Ensembl chr13:32,687,042...32,699,835
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19932
role
19904
biological role
19902
biochemical role
19598
metabolite
19585
alkaloid
8012
ergoline alkaloid
21
(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
4
(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
1
10-Hydroxy-trans-paspalic acid Amide
0
6-Methyl-9,10-didehydroergoline-8-carboxylic acid
0
6-allyl-8b-Carboxy-ergoline
0
6-methylergoline +
0
D-Lysergic acid N,N-diethylamide
0
Dhesn
0
Ergometrinine
0
Methylergonovine Maleate
1
Methysergide maleate
0
N-(1-hydroxybutan-2-yl)-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
0
N-(1-hydroxybutan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
0
N-(1-hydroxypropan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
0
N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
0
ergoline +
19
lysergamide +
5
lysergic acid +
0
lysergic acid diethylamide +
5
lysergol
1
metergoline
4
Path 2
CHEBI ontology
19932
subatomic particle
19930
composite particle
19930
hadron
19930
baryon
19930
nucleon
19930
atomic nucleus
19930
atom
19930
main group element atom
19876
main group molecular entity
19876
p-block molecular entity
19876
carbon group molecular entity
19816
organic molecular entity
19812
heteroorganic entity
19559
organonitrogen compound
18871
alkaloid
8012
ergoline alkaloid
21
(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
4
(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
1
10-Hydroxy-trans-paspalic acid Amide
0
6-Methyl-9,10-didehydroergoline-8-carboxylic acid
0
6-allyl-8b-Carboxy-ergoline
0
6-methylergoline +
0
D-Lysergic acid N,N-diethylamide
0
Dhesn
0
Ergometrinine
0
Methylergonovine Maleate
1
Methysergide maleate
0
N-(1-hydroxybutan-2-yl)-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
0
N-(1-hydroxybutan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
0
N-(1-hydroxypropan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
0
N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
0
ergoline +
19
lysergamide +
5
lysergic acid +
0
lysergic acid diethylamide +
5
lysergol
1
metergoline
4